Cardioprotective 3',4'-dihydroxyflavonol attenuation of JNK and p38(MAPK) signalling involves CaMKII inhibition.
about
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesParaquat Induces Apoptosis through Cytochrome C Release and ERK ActivationCardioprotective Effect of Licochalcone D against Myocardial Ischemia/Reperfusion Injury in Langendorff-Perfused Rat Hearts.Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction.Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.Protective effect of apigenin on ischemia/reperfusion injury of the isolated rat heart.
P2860
Cardioprotective 3',4'-dihydroxyflavonol attenuation of JNK and p38(MAPK) signalling involves CaMKII inhibition.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cardioprotective 3',4'-dihydro ...... ng involves CaMKII inhibition.
@en
Cardioprotective 3',4'-dihydro ...... ng involves CaMKII inhibition.
@nl
type
label
Cardioprotective 3',4'-dihydro ...... ng involves CaMKII inhibition.
@en
Cardioprotective 3',4'-dihydro ...... ng involves CaMKII inhibition.
@nl
prefLabel
Cardioprotective 3',4'-dihydro ...... ng involves CaMKII inhibition.
@en
Cardioprotective 3',4'-dihydro ...... ng involves CaMKII inhibition.
@nl
P2093
P2860
P50
P356
P1433
P1476
Cardioprotective 3',4'-dihydro ...... ing involves CaMKII inhibition
@en
P2093
Clive N May
Colleen J Thomas
James R Bell
Lea M D Delbridge
Lokugan S Silva
Yvonne Y Yeap
P2860
P304
P356
10.1042/BJ20121538
P407
P577
2013-12-01T00:00:00Z